Search

for
Search:

GlossaryAllogeneic Hematopoietic Stem Cell Transplantation

transplanting stem cells from a genetically similar donor

Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) is a medical procedure where a patient receives stem cells from a genetically similar, but not identical, donor. These stem cells can develop into different types of blood cells and are used to replace damaged or diseased bone marrow, often in the treatment of conditions like leukemia, lymphoma, or severe aplastic anemia.

Related Terms

Research

5 / 1000+ results

research A case of lupus miliaris disseminatus faciei after allogeneic hematopoietic stem cell transplantation

1 citations , August 2019 in “Chinese Medical Journal”

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

Rapid Full Engraftment and Successful Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Conditioning in Omenn Syndrome

research Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome

8 citations , August 2009 in “Pediatric transplantation”

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Permanent Diffuse Alopecia After Hematopoietic Stem Cell Transplantation in Childhood

research Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood

16 citations , March 2017 in “Bone Marrow Transplantation”

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Hemorrhagic Cystitis in Allogeneic Stem Cell Transplantation: A Role for Age and Prostatic Hyperplasia

research Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia

5 citations , February 2022 in “Supportive Care in Cancer”

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Hemorrhagic Cystitis in Allogeneic Stem Cell Transplantation: A Role for Age and Prostatic Hyperplasia

research Hemorrhagic Cystitis in Allogeneic Stem Cell Transplantation: A Role for Age and Prostatic Hyperplasia

2 citations , October 2021 in “Research Square (Research Square)”

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

View more "allogeneic hematopoietic stem cell transplantation" in research →

Clinics

6 / 64 results

All 64 clinic results →

Experts

6 / 21 results

All 21 expert results →

Learn

— no results

Try a deeper search in learn →

Community Join

— no results

Try a deeper search in community →